Since NEO1 and LATS2 are tumor-suppressor genes and at the same time target genes for p53 and hsa-mir-372 and 373, both hsa-mir-372 and 373 may suppress the p53 pathway by destabilizing NEO1s and LATS2s transcript and/or by inhibiting their translation. This evidence concerns the gene TP53 and neoplasm.